stella
beta
An Exploratory Study of Cluster of Differentiation 38 (CD38) Monoclonal Antibody Combined Corticosteroid in Acquired Hemophilia A — Stella
Recruiting
Back to Acquired Hemophilia trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(1 site)
China
Chinese Academy of Medical Science and Blood Disease Hospital, Tianjin
View full record on ClinicalTrials.gov